Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Avanos Medical, Inc. to Present at the Raymond James 40th Annual Institutional Investors Conference

AVNS

PR Newswire

ALPHARETTA, Ga., Feb. 27, 2019 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Steve Voskuil, chief financial officer, will present at the Raymond James 40th Annual Institutional Investors Conference on Wednesday, March 6 at approximately 11 a.m. ET at the JW Marriott Orlando Grande Lakes in Orlando, Florida.

(PRNewsfoto/Avanos Medical Inc.)

A webcast of the conference presentation and Q&A session will be available on the Investors section of the Avanos Medical website and will be archived on that site.

About Avanos Medical:
Avanos Medical (NYSE: AVNS) is a medical technology company focused on delivering clinically superior breakthrough medical device solutions to improve patients' quality of life. Headquartered in Alpharetta, Georgia, Avanos is committed to addressing some of today's most important healthcare needs, such as reducing the use of opioids while helping patients move from surgery to recovery. Avanos develops, manufactures and markets its recognized brands in more than 90 countries. For more information, visit www.avanos.com.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/avanos-medical-inc-to-present-at-the-raymond-james-40th-annual-institutional-investors-conference-300802806.html

SOURCE Avanos Medical, Inc.